edelfosine has been researched along with glycolipids in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 6 (46.15) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rohdewald, P; Schaefer, HG | 1 |
Boucrot, P; Lelain, R; Petit, JY; Welin, L | 1 |
Magistrelli, A; Salmona, M; Tacconi, MT; Trulla, LL | 1 |
Fisher, MC; Mar, MH; Sadler, TW; Zeisel, SH | 1 |
Budde, M; Caan, W; Klarenbeek, JB; Van Blitterswijk, WJ; Van der Luit, AH; Verheij, M; Zerp, S | 1 |
Klarenbeek, JB; Perrissoud, D; Solary, E; van Blitterswijk, WJ; van der Luit, AH; Verheij, M; Vink, SR | 1 |
Aranda, FJ; Ausili, A; Corbalán-García, S; de Godos, A; Gajate, C; Gómez-Fernández, JC; Mollinedo, F; Torrecillas, A | 1 |
Dynarowicz-Łatka, P; Hac-Wydro, K | 2 |
Bąk, K; Dynarowicz-Łątka, P; Hąc-Wydro, K; Wydro, P | 1 |
Bougnoux, P; Chantome, A; Corbel, B; Couthon-Gourvès, H; Girault, A; Haelters, JP; Jaffrès, PA; Joulin, V; Marionneau-Lambot, S; Oullier, T; Pinault, M; Potier-Cartereau, M; Simon, G; Vandier, C | 1 |
Dynarowicz-Latka, P; Hac-Wydro, K | 1 |
Besson, P; Bouchet, AM; Bougnoux, P; Chantôme, A; Couthon-Gourvès, H; Gajate, C; Jaffrès, PA; Mollinedo, F; Potier-Cartereau, M; Vandier, C | 1 |
2 review(s) available for edelfosine and glycolipids
Article | Year |
---|---|
Edelfosine in membrane environment - the Langmuir monolayer studies.
Topics: Antineoplastic Agents; Cholesterol; Gangliosides; Humans; Membrane Fluidity; Membrane Microdomains; Neoplasms; Phospholipid Ethers; Sphingomyelins; Unilamellar Liposomes | 2014 |
Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Movement; Drug Design; Glycolipids; Humans; Ion Channels; Membrane Microdomains; Molecular Structure; Neoplasm Invasiveness; Neoplasms; Phospholipid Ethers; Signal Transduction; Structure-Activity Relationship | 2016 |
11 other study(ies) available for edelfosine and glycolipids
Article | Year |
---|---|
Determination of the alkyl lysophospholipid derivative ET-18-OCH3, a new antineoplastic drug, in plasma.
Topics: Administration, Oral; Antineoplastic Agents; Chromatography, Thin Layer; Densitometry; Humans; Phospholipid Ethers; Phospholipids; Sphingomyelins; Statistics as Topic | 1989 |
Effect of octadecylmethylglycerophosphocholine and hexadecylmethylglycerol on arachidonic acylation or release in macrophages.
Topics: Acetylation; Animals; Antineoplastic Agents; Arachidonic Acid; Cells, Cultured; Fatty Acids; Glyceryl Ethers; Glycolipids; Isotope Labeling; Kinetics; Macrophages, Peritoneal; Male; Phospholipid Ethers; Protein Kinase C; Rats; Rats, Wistar; Tritium | 1994 |
Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma.
Topics: Animals; Antineoplastic Agents; Cell Count; Cell Survival; Cholesterol; Melanoma, Experimental; Mice; Phosphatidylcholines; Phospholipid Ethers; Phospholipids; Sphingomyelins; Tumor Cells, Cultured | 1993 |
Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro.
Topics: Acetylcholine; Animals; Betaine; Cells, Cultured; Central Nervous System; Ceramides; Choline; Deanol; Diglycerides; Embryo, Mammalian; Embryonic and Fetal Development; Gastrula; Mice; Models, Neurological; Phosphatidylcholines; Phospholipid Ethers; Phosphorylcholine; Sphingomyelins | 2002 |
Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts.
Topics: Androstenes; Animals; Apoptosis; Bridged-Ring Compounds; Cholesterol; Down-Regulation; Endocytosis; Fatty Acids, Monounsaturated; Gene Expression; Membrane Microdomains; Mice; Norbornanes; Phospholipid Ethers; RNA, Small Interfering; Sphingomyelins; Thiocarbamates; Thiones; Transferases (Other Substituted Phosphate Groups); Tumor Cells, Cultured | 2007 |
A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Endocytosis; HeLa Cells; Humans; Lymphoma; Membrane Microdomains; Mice; Phosphatidylcholines; Phospholipid Ethers; Phospholipids; Phosphorylcholine; Sphingomyelins; Time Factors | 2007 |
Edelfosine is incorporated into rafts and alters their organization.
Topics: Antineoplastic Agents; Calorimetry, Differential Scanning; Cell Membrane; Cholesterol; Humans; Jurkat Cells; Magnetic Resonance Spectroscopy; Phase Transition; Phosphatidylcholines; Phosphodiesterase Inhibitors; Phospholipid Ethers; Sphingomyelins; Temperature; X-Ray Diffraction | 2008 |
The relationship between the concentration of ganglioside GM1 and antitumor activity of edelfosine--the Langmuir monolayer study.
Topics: Adsorption; Algorithms; Antineoplastic Agents; Cholesterol; Dose-Response Relationship, Drug; G(M1) Ganglioside; Lipid Bilayers; Membranes, Artificial; Phospholipid Ethers; Sphingomyelins; Surface Properties; Thermodynamics | 2010 |
Searching for the role of membrane sphingolipids in selectivity of antitumor ether lipid-edelfosine.
Topics: Air; Antineoplastic Agents; Gangliosides; Membranes, Artificial; Molecular Structure; Phospholipid Ethers; Sphingomyelins; Thermodynamics; Water | 2010 |
Edelfosine disturbs the sphingomyelin-cholesterol model membrane system in a cholesterol-dependent way - the Langmuir monolayer study.
Topics: Cholesterol; Membranes, Artificial; Phospholipid Ethers; Sphingomyelins | 2011 |
New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Female; Glycolipids; Humans; Mice; Mice, Nude; Molecular Structure; Phospholipid Ethers; Platelet Membrane Glycoproteins; Potassium Channel Blockers; Protein Kinase C; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; Small-Conductance Calcium-Activated Potassium Channels; Structure-Activity Relationship | 2011 |